0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-08-01 Sage Accounts Production Advanced 2024 - FRS102_2024 7,442 6,351 563 6,914 528 1,091 xbrli:pure xbrli:shares iso4217:GBP 06959553 2023-08-01 2024-07-31 06959553 2024-07-31 06959553 2023-07-31 06959553 2022-08-01 2023-07-31 06959553 2023-07-31 06959553 2022-07-31 06959553 core:FurnitureFittings 2023-08-01 2024-07-31 06959553 bus:OrdinaryShareClass1 2023-08-01 2024-07-31 06959553 bus:Director1 2023-08-01 2024-07-31 06959553 core:FurnitureFittings 2023-07-31 06959553 core:FurnitureFittings 2024-07-31 06959553 core:WithinOneYear 2024-07-31 06959553 core:WithinOneYear 2023-07-31 06959553 core:ShareCapital 2024-07-31 06959553 core:ShareCapital 2023-07-31 06959553 core:RetainedEarningsAccumulatedLosses 2024-07-31 06959553 core:RetainedEarningsAccumulatedLosses 2023-07-31 06959553 core:FurnitureFittings 2023-07-31 06959553 bus:SmallEntities 2023-08-01 2024-07-31 06959553 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 06959553 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 06959553 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 06959553 bus:FullAccounts 2023-08-01 2024-07-31 06959553 bus:OrdinaryShareClass1 2024-07-31 06959553 bus:OrdinaryShareClass1 2023-07-31
COMPANY REGISTRATION NUMBER: 06959553
AMPTHILL OSTEOPATHY LIMITED
Filleted Unaudited Financial Statements
For the year ended
31 July 2024
AMPTHILL OSTEOPATHY LIMITED
Financial Statements
Year ended 31 July 2024
Contents
Pages
Statement of financial position
1 to 2
Notes to the financial statements
3 to 5
AMPTHILL OSTEOPATHY LIMITED
Statement of Financial Position
31 July 2024
2024
2023
Note
£
£
£
Fixed assets
Tangible assets
4
528
1,091
Current assets
Stocks
461
392
Cash at bank and in hand
6,029
6,722
-------
-------
6,490
7,114
Creditors: amounts falling due within one year
5
3,660
6,016
-------
-------
Net current assets
2,830
1,098
-------
-------
Total assets less current liabilities
3,358
2,189
-------
-------
Net assets
3,358
2,189
-------
-------
Capital and reserves
Called up share capital
6
1
1
Profit and loss account
3,357
2,188
-------
-------
Shareholder funds
3,358
2,189
-------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
AMPTHILL OSTEOPATHY LIMITED
Statement of Financial Position (continued)
31 July 2024
These financial statements were approved by the board of directors and authorised for issue on 12 February 2025 , and are signed on behalf of the board by:
Nola Anne Todhunter
Director
Company registration number: 06959553
AMPTHILL OSTEOPATHY LIMITED
Notes to the Financial Statements
Year ended 31 July 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 8 Flitwick Road, Maulden, Bedford, MK45 2BJ, England.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in UK sterling, which is the functional currency of the entity. Monetary amounts in these financial statements are rounded to the nearest UK pound.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fixtures, fittings and equipment
-
25% straight line
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
4. Tangible assets
Fixtures, fittings and equipment
Total
£
£
Cost
At 1 August 2023 and 31 July 2024
7,442
7,442
-------
-------
Depreciation
At 1 August 2023
6,351
6,351
Charge for the year
563
563
-------
-------
At 31 July 2024
6,914
6,914
-------
-------
Carrying amount
At 31 July 2024
528
528
-------
-------
At 31 July 2023
1,091
1,091
-------
-------
5. Creditors: amounts falling due within one year
2024
2023
£
£
Social security and other taxes
642
790
Other creditors
3,018
5,226
-------
-------
3,660
6,016
-------
-------
6. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary shares of £ 1 each
1
1
1
1
----
----
----
----